These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

924 related articles for article (PubMed ID: 26209116)

  • 1. Innate and adaptive immunity against Porcine Reproductive and Respiratory Syndrome Virus.
    Loving CL; Osorio FA; Murtaugh MP; Zuckermann FA
    Vet Immunol Immunopathol; 2015 Sep; 167(1-2):1-14. PubMed ID: 26209116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
    Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
    Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic B- and T-cell epitope peptides of porcine reproductive and respiratory syndrome virus with Gp96 as adjuvant induced humoral and cell-mediated immunity.
    Chen C; Li J; Bi Y; Yang L; Meng S; Zhou Y; Jia X; Meng S; Sun L; Liu W
    Vaccine; 2013 Apr; 31(14):1838-47. PubMed ID: 23395588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
    Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems Immunology Analyses Following Porcine Respiratory and Reproductive Syndrome Virus Infection and Vaccination.
    Bocard LV; Kick AR; Hug C; Lischer HEL; Käser T; Summerfield A
    Front Immunol; 2021; 12():779747. PubMed ID: 34975868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of Adaptive Immunity to Porcine Reproductive and Respiratory Syndrome Virus.
    Rahe MC; Murtaugh MP
    Viruses; 2017 Jun; 9(6):. PubMed ID: 28608816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses of pigs immunized with a recombinant porcine reproductive and respiratory syndrome virus expressing porcine GM-CSF.
    Li Z; Wang G; Wang Y; Zhang C; Huang B; Li Q; Li L; Xue B; Ding P; Cai X; Wang C; Zhou EM
    Vet Immunol Immunopathol; 2015 Nov; 168(1-2):40-8. PubMed ID: 26300317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PBMC transcriptome profiles identifies potential candidate genes and functional networks controlling the innate and the adaptive immune response to PRRSV vaccine in Pietrain pig.
    Islam MA; Große-Brinkhaus C; Pröll MJ; Uddin MJ; Aqter Rony S; Tesfaye D; Tholen E; Hoelker M; Schellander K; Neuhoff C
    PLoS One; 2017; 12(3):e0171828. PubMed ID: 28278192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant.
    Chia MY; Hsiao SH; Chan HT; Do YY; Huang PL; Chang HW; Tsai YC; Lin CM; Pang VF; Jeng CR
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):234-42. PubMed ID: 20053461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication-competent recombinant porcine reproductive and respiratory syndrome (PRRS) viruses expressing indicator proteins and antiviral cytokines.
    Sang Y; Shi J; Sang W; Rowland RR; Blecha F
    Viruses; 2012 Jan; 4(1):102-16. PubMed ID: 22355454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of Systems to Enable Isolation of Porcine Monoclonal Antibodies Broadly Neutralizing the Porcine Reproductive and Respiratory Syndrome Virus.
    Goldeck D; Perry DM; Hayes JWP; Johnson LPM; Young JE; Roychoudhury P; McLuskey EL; Moffat K; Bakker AQ; Kwakkenbos MJ; Frossard JP; Rowland RRR; Murtaugh MP; Graham SP
    Front Immunol; 2019; 10():572. PubMed ID: 30972067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
    Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
    Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of host immune responses to homologous and heterologous type II porcine reproductive and respiratory syndrome virus (PRRSV) challenge in vaccinated and unvaccinated pigs.
    Li X; Galliher-Beckley A; Pappan L; Trible B; Kerrigan M; Beck A; Hesse R; Blecha F; Nietfeld JC; Rowland RR; Shi J
    Biomed Res Int; 2014; 2014():416727. PubMed ID: 24719862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
    Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
    Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcine reproductive and respiratory syndrome (PRRS) virus-specific interferon-gamma(+) T-cell responses after PRRS virus infection or vaccination with an inactivated PRRS vaccine.
    Piras F; Bollard S; Laval F; Joisel F; Reynaud G; Charreyre C; Andreoni C; Juillard V
    Viral Immunol; 2005; 18(2):381-9. PubMed ID: 16035950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon alpha inhibits replication of a live-attenuated porcine reproductive and respiratory syndrome virus vaccine preventing development of an adaptive immune response in swine.
    Brockmeier SL; Loving CL; Eberle KC; Hau SJ; Buckley A; Van Geelen A; Montiel NA; Nicholson T; Lager KM
    Vet Microbiol; 2017 Dec; 212():48-51. PubMed ID: 29173587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.
    Ko SS; Seo SW; Sunwoo SY; Yoo SJ; Kim MH; Lyoo YS
    Vet Immunol Immunopathol; 2016 Apr; 172():43-9. PubMed ID: 27032502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
    Zhang Z; Wang Y; Fan H; Lu C
    Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-protection of a new type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccine (Fostera PRRS) against heterologous type 1 PRRSV challenge in growing pigs.
    Park C; Choi K; Jeong J; Chae C
    Vet Microbiol; 2015 May; 177(1-2):87-94. PubMed ID: 25769646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell-targeted porcine reproductive and respiratory syndrome virus (PRRSV) antigens adjuvanted with polyinosinic-polycytidylic acid (poly (I:C)) induced non-protective immune responses against heterologous type 2 PRRSV challenge in pigs.
    Subramaniam S; Piñeyro P; Derscheid RJ; Madson DM; Magstadt DR; Meng XJ
    Vet Immunol Immunopathol; 2017 Aug; 190():18-25. PubMed ID: 28778318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.